DrugDashboards

Market view

theophylline anhydrous · Capsule, Extended Release

4 marketed package NDCs · 1 active manufacturer

Most dispensed: 200 mg · Capsule, Extended Release · #100 capsule, extended releases/bottle · 100 mg · Capsule, Extended Release · #100 capsule, extended releases/bottle · 400 mg · Capsule, Extended Release · #100 capsule, extended releases/bottle · 300 mg · Capsule, Extended Release · #100 capsule, extended releases/bottle

The short version

Only one company currently supplies this market — there is no backup if it stumbles. The price is down 12% over the past year, to $5.38 per unit.

Price range and competition

RSS: changes for this drug

Every company selling this drug reports its own price. The line follows the middle of the pack; the shaded band holds the middle half of companies — the wider it is, the more they disagree.

$0$5.00$10.00Jan 2015Sep 202601companies actively selling

Latest · Sep 2026 — typical price $5.38 · middle half $4.60$6.17 · full range $3.82$6.95 · 2 products · 1 companies

middle half of companies’ pricestypical (median) pricecompanies actively selling (bottom lane)Priced per unitSource: CMS NADAC
ⓘ How this was built
Data sources
  • CMS NADAC weekly survey + monthly archives back to 2013 (data.medicaid.gov)
  • CMS Federal Upper Limit files (weighted AMP)
  • FDA NDC Directory (openFDA) — maker roster
Method

Each month's band spans the NADAC unit prices of every NDC of this drug (min, quartiles, median, max), split into brand and generic cohorts by FDA marketing category. Maker counts come from distinct labelers with the NDC actively listed.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

What changed in the last 90 days

Every detected change for theophylline anhydrous, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.

  • Price up
    NADAC $0.99782 → $1.01514 per unit (+1.74%)
  • Theo-24Aug 19, 2026
    Price down
    NADAC $6.95958 → $6.95288 per unit (-0.1%)
  • Theo-24Aug 19, 2026
    Price up
    NADAC $3.81323 → $3.81613 per unit (+0.08%)
  • Price up
    NADAC $0.95764 → $0.99782 per unit (+4.2%)
  • Theo-24Jul 22, 2026
    Price up
    NADAC $6.95151 → $6.95958 per unit (+0.12%)
  • Theo-24Jul 22, 2026
    Price down
    NADAC $3.82603 → $3.81323 per unit (-0.33%)

Same drug class

Other molecules FDA puts in Methylxanthine, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.

Common questions

Is Theophylline anhydrous in shortage right now?
No. FDA does not currently list Theophylline anhydrous in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
Who makes Theophylline anhydrous?
4 companies have marketed Theophylline anhydrous in the last 30 days, according to the FDA NDC Directory. Every manufacturer and package is listed on this page.
What does Theophylline anhydrous cost?
The typical pharmacy pays about $3.82 per unit, based on the most recent CMS NADAC survey of actual acquisition costs. That is what the pharmacy pays for the drug itself — not the cash price, and not what an insurer is billed.

All marketed products

Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.